76 related articles for article (PubMed ID: 6984302)
21. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
Potlukova E; Kralikova P
Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
[TBL] [Abstract][Full Text] [Related]
22. Lymphocytotoxins in rheumatoid arthritis.
Levo Y; Waisman Y; Ehrenfeld M
Isr J Med Sci; 1980 Nov; 16(11):791-4. PubMed ID: 6969241
[No Abstract] [Full Text] [Related]
23. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
[TBL] [Abstract][Full Text] [Related]
24. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited.
Korb LC; Ahearn JM
J Immunol; 1997 May; 158(10):4525-8. PubMed ID: 9144462
[TBL] [Abstract][Full Text] [Related]
25. Reduced expression of C1q-mRNA in monocytes from patients with systemic lupus erythematosus.
Moosig F; Damm F; Knorr-Spahr A; Ritgen M; Zeuner RA; Kneba M; Ernst M; Schröder JO
Clin Exp Immunol; 2006 Dec; 146(3):409-16. PubMed ID: 17100759
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of patients with systemic lupus erythematosus by immunoadsorption with a C1q column: a pilot study.
Pfueller B; Wolbart K; Bruns A; Burmester GR; Hiepe F
Arthritis Rheum; 2001 Aug; 44(8):1962-3. PubMed ID: 11508450
[No Abstract] [Full Text] [Related]
27. Reduced anti-TNFalpha autoantibody levels coincide with flare in systemic lupus erythematosus.
Sjöwall C; Ernerudh J; Bengtsson AA; Sturfelt G; Skogh T
J Autoimmun; 2004 Jun; 22(4):315-23. PubMed ID: 15120755
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P
J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471
[TBL] [Abstract][Full Text] [Related]
29. [C1q deficiency in systemic lupus erythematosus].
Garred P; Morling N
Ugeskr Laeger; 1999 Oct; 161(42):5809. PubMed ID: 10578698
[No Abstract] [Full Text] [Related]
30. Development of systemic lupus erythematosus in a patient with selective complete C1q deficiency.
Berkel AI; Petry F; Sanal O; Tinaztepe K; Ersoy F; Bakkaloglu A; Loos M
Eur J Pediatr; 1997 Feb; 156(2):113-5. PubMed ID: 9039514
[TBL] [Abstract][Full Text] [Related]
31. A selective and complete absence of C1q in a patient with vasculitis and nephritis.
Minta JO; Winkler CJ; Biggar WD; Greenberg M
Clin Immunol Immunopathol; 1982 Feb; 22(2):225-37. PubMed ID: 7049461
[No Abstract] [Full Text] [Related]
32. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
Zhang FC; Zhou B; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
[TBL] [Abstract][Full Text] [Related]
33. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
[TBL] [Abstract][Full Text] [Related]
34. Rapid improvement of SLE-specific cutaneous lesions by C1q immunoadsorption.
Berner B; Scheel AK; Schettler V; Hummel KM; Reuss-Borst MA; Müller GA; Oestmann E; Leinenbach HP; Hepper M
Ann Rheum Dis; 2001 Sep; 60(9):898-9. PubMed ID: 11534506
[No Abstract] [Full Text] [Related]
35. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients.
Tsacheva I; Radanova M; Todorova N; Argirova T; Kishore U
Mol Immunol; 2007 Mar; 44(8):2147-51. PubMed ID: 17049989
[TBL] [Abstract][Full Text] [Related]
36. Relevance of anti-C1q autoantibodies to lupus nephritis.
Tsirogianni A; Pipi E; Soufleros K
Ann N Y Acad Sci; 2009 Sep; 1173():243-51. PubMed ID: 19758158
[TBL] [Abstract][Full Text] [Related]
37. Antibodies to the collagen-like region of C1q and type II collagen are independent non-cross-reactive populations in systemic lupus erythematosus and rheumatoid arthritis.
Cook AD; Rowley MJ; Wines BD; Mackay IR
J Autoimmun; 1994 Jun; 7(3):369-78. PubMed ID: 7522456
[TBL] [Abstract][Full Text] [Related]
38. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
[TBL] [Abstract][Full Text] [Related]
39. Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?
Shoenfeld Y; Meroni PL; Toubi E
Curr Opin Rheumatol; 2009 Sep; 21(5):495-500. PubMed ID: 19593144
[TBL] [Abstract][Full Text] [Related]
40. A patient with hereditary C1q deficiency.
Ozsoylu S
Turk J Pediatr; 2010; 52(6):674; author reply 674. PubMed ID: 21428208
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
